Andrew Eng

Andrew Eng has an extensive background in life sciences innovation and contracts management. They served as a Laboratory Technician at the University of Pennsylvania and gained a PhD in Neuroscience from Northwestern University. Andrew's professional experience includes roles as a Patentability and Marketing Analyst at the Innovation and New Ventures Office, a Technology Licensing Associate at MIT, and as a Contracts Specialist at Lyndra Therapeutics. They currently hold the position of Associate Director in Early Phase Oncology Business Operations at Eli Lilly and Company.